MD897G2 - Method for lymphosarcoma and acute lympholeukosis differencial diagnosis - Google Patents

Method for lymphosarcoma and acute lympholeukosis differencial diagnosis

Info

Publication number
MD897G2
MD897G2 MD97-0122A MD970122A MD897G2 MD 897 G2 MD897 G2 MD 897G2 MD 970122 A MD970122 A MD 970122A MD 897 G2 MD897 G2 MD 897G2
Authority
MD
Moldova
Prior art keywords
lympholeukosis
lymphosarcoma
acute
diagnosis
differencial
Prior art date
Application number
MD97-0122A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD897F1 (en
Inventor
Ludmila Gavriluc
Original Assignee
Universitatea Libera Internationala Din Republica Moldova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatea Libera Internationala Din Republica Moldova filed Critical Universitatea Libera Internationala Din Republica Moldova
Priority to MD97-0122A priority Critical patent/MD897G2/en
Publication of MD897F1 publication Critical patent/MD897F1/en
Publication of MD897G2 publication Critical patent/MD897G2/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to the medicine, particularly, to the clinical biochemistry and may be used in the lymphosarcoma and acute lympholeukosis differencial diagnosis on the leukemia stage.Method for lymphosarcoma and acute lympholeukosis differencial diagnosis, accordingly to the invention, includes glutathione reductase activity, glutathione peroxidase and glutathionedehydroascorbat reductase determination with further determination of the value of glutathione reductase activity relation to the glutathione peroxidase and glutathionedehydroascorbat reductase activities sum, so as in case of value lower than 0,025 is carried out the lymphosarcoma diagnosis, and in case of the value more than 0,095 is diagnosticated the acute lympholeukosis.The technical result of the invention consists in increasing the grade of the lymphosarcoma and acute lympholeukosis correct diagnosis.
MD97-0122A 1997-03-28 1997-03-28 Method for lymphosarcoma and acute lympholeukosis differencial diagnosis MD897G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD97-0122A MD897G2 (en) 1997-03-28 1997-03-28 Method for lymphosarcoma and acute lympholeukosis differencial diagnosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD97-0122A MD897G2 (en) 1997-03-28 1997-03-28 Method for lymphosarcoma and acute lympholeukosis differencial diagnosis

Publications (2)

Publication Number Publication Date
MD897F1 MD897F1 (en) 1998-01-31
MD897G2 true MD897G2 (en) 1998-09-30

Family

ID=19739004

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0122A MD897G2 (en) 1997-03-28 1997-03-28 Method for lymphosarcoma and acute lympholeukosis differencial diagnosis

Country Status (1)

Country Link
MD (1) MD897G2 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Res. Cancer. Epidemiol. S. R. Heckbert. "Glutathione transferase and epoxide hydrolase activities in patients with cancer and controls", 1989, Lyon, p. 515-516. *

Also Published As

Publication number Publication date
MD897F1 (en) 1998-01-31

Similar Documents

Publication Publication Date Title
ATE133181T1 (en) DEHYDRODIDEMNINE B
ES8900017A1 (en) N,N-dialkylguanidino dipeptides.
BG102071A (en) Minor molecule inhibitors of rotamase enzymic activity
MX9709472A (en) MUTANT 'alpha'-AMYLASE.
CA2295693A1 (en) Mutant .alpha.-amylase having introduced therein a disulfide bond
PT799578E (en) COMBINED PREPARATION CONTAINING GERMES ENRICHED WITH ELECTROLYTES
AU1917095A (en) 6-substituted mycophenolic and derivatives with immunosuppressive activity
GR3030874T3 (en) Determination of glycated proteins
MX9800499A (en) Inhibition of gene expression.
WO1997020933A3 (en) Mutational variants of mammalian ob gene proteins
NO20014091D0 (en) Transplantation of hematopoietic cells
NZ333577A (en) Polynucleotides and fragments thereof of lysyl oxidase
GB2380939B (en) Treatment or prevention of auto-immune diseases
MD897G2 (en) Method for lymphosarcoma and acute lympholeukosis differencial diagnosis
EP0330218A3 (en) Inhibitors of lysyl oxidase
AU6989998A (en) Amino acid compositions and use thereof in clinical nutrition
WO1997044346A3 (en) Specific inhibitors of dna methyltransferase enzyme
AU6877587A (en) Expellants of phytopathogenic microbes
ES2122912A1 (en) Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents
Reddy et al. Inhibitory effects of phosphamidon on acetylcholinesterase enzyme system of the nervous tissue of Ocypode platytarsis
EP0255106A3 (en) Process for the production of corrosion-resistant steels and castings
Letona et al. Analysis and Evaluation of the Influence of Titanium Compound Inclusions in the Machinability of Steel F-1140
AU9286098A (en) Agent for modifying the proliferation, functional activity and death of natural and tumoral cells
MD1218G2 (en) Antimutagenic agent
IT245829Y1 (en) SAFETY COMPASS FOR THE CONTROL OF ACCESS TO AN ENVIRONMENT, IN PARTICULAR FOR JEWELERY AND SIMILAR.

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20170328